Document is current
Any future updates will be listed below
-
Authors
Vallentgoed, Wies R. https://orcid.org/0000-0001-6373-7710
Hoogstrate, Youri https://orcid.org/0000-0003-2166-0676
van Garderen, Karin A.
van Hijfte, Levi https://orcid.org/0000-0002-1402-6784
van Dijk, Erik https://orcid.org/0000-0002-6272-2039
Kouwenhoven, Mathilde C. M.
Niers, Johanna M.
Draaisma, Kaspar
Martin, Ivonne
de Leng, Wendy W. J.
Tesileanu, C. Mircea S.
de Heer, Iris
Diepeveen, Maud
Lavrova, Anna https://orcid.org/0009-0001-7521-7082
Eijk, Paul P.
Bühler, Marcel https://orcid.org/0000-0001-9608-1316
Wick, Wolfgang https://orcid.org/0000-0002-6171-634X
Clement, Paul M.
Sanson, Marc
Franceschi, Enrico
Gorlia, Thierry
Golfinopoulos, Vassilis
Weller, Michael https://orcid.org/0000-0002-1748-174X
Weiss, Tobias https://orcid.org/0000-0002-5533-9429
Robe, Pierre A.
Kros, Johan M.
Smits, Marion https://orcid.org/0000-0001-5563-2871
van de Wiel, Mark https://orcid.org/0000-0003-4780-8472
Ylstra, Bauke https://orcid.org/0000-0001-9479-3010
Verhaak, Roel G. W. https://orcid.org/0000-0003-2773-0436
van den Bent, Martin J. https://orcid.org/0000-0001-5710-5127
Westerman, Bart A. https://orcid.org/0000-0002-9898-9616
Wesseling, Pieter https://orcid.org/0000-0001-5453-5201
French, Pim J. https://orcid.org/0000-0002-0668-9529
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 18 June 2025
First Online: 19 August 2025
Competing interests
: P.J.F. declares research support from Servier. E.F. declares research support from Incyte Steering committee (uncompensated) and is on the Genenta Science advisory board. M.W. has received research grants from Novartis, Quercis and Versameb and honoraria for lectures or advisory board participation or consulting from Anheart, Bayer, Curevac, Medac, Neurosense, Novartis, Novocure, Orbus, Pfizer, Philogen, Roche and Servier. R.G.W.V. is cofounder of and holds equity in Boundless Bio. The remaining authors declare no competing interests.
